Amplatzer piccolo PDA occluder use in pediatric surgery

The University of New Mexico (UNM) is seeking a sole source procurement of the Amplatzer Piccolo PDA Occluder, a specialized medical device for pediatric cardiovascular surgery, specifically designed for Patent Ductus Arteriosus (PDA) closure in premature infants weighing 700 grams and above. The procurement targets Abbott as the exclusive vendor, with the device being the only FDA-approved product of its kind in the United States. Key technical specifications include an extremely low-profile 4 F catheter delivery system, a self-expanding design for precise PDA closure, a tightly woven single-layer mesh, and a flexible delivery cable enabling accurate positioning. The contract is proposed for a three-year term with an annual value of $70,000 and potential renewals consistent with New Mexico Procurement Code. The opportunity is open to vendors within Bernalillo County and Albuquerque City, with a posted date of June 26, 2025, and a submission deadline of July 26, 2025. The procurement will undergo a mandatory 30-day review period, during which the document will be posted on the UNM Sunshine Portal and New Mexico Procurement website.

The sole source procurement appears to have no specific set-aside designations or restrictions on responding organizations. Abbott, located at 8701 Bee Cave Road in Austin, Texas, is the sole identified vendor for this specialized medical device. An extensive web search was conducted to confirm no alternative vendors could meet the specific medical device requirements, which supports the sole source justification. The proposed contract value indicates a total potential three-year investment of $210,000, with the possibility of future renewals. The procurement is specifically for the Amplatzer Piccolo PDA Occluder, which represents a highly specialized medical technology with unique engineering characteristics that meet precise pediatric surgical needs. The document was electronically signed by Jeffrey Gilmore on June 26, 2025, further validating the procurement process. While no specific integration requirements are mentioned, the device will be used within the University of New Mexico Hospital's cardiovascular services department.